a Department of Biochemistry and Molecular Biology , Southern Illinois University School of Medicine , Carbondale , Illinois , USA.
Cell Cycle. 2019 Feb;18(4):476-499. doi: 10.1080/15384101.2019.1578133. Epub 2019 Feb 12.
HepaRG is a proliferative human hepatoma-derived cell line that can be differentiated into hepatocyte-like and biliary-like cells. Differentiated HepaRG cultures maintain key hepatic functions including drug transporters and xenobiotic-metabolizing enzymes. To gain insight into proliferative and differentiated HepaRG metabolism we profiled various bioenergetic parameters and investigated cell culture levels of adenosine triphosphate (ATP), lactate, and lactate dehydrogenase (LDH) activity. Compared to differentiated-derived HepaRG, cells from proliferative cultures had increased basal and ATP-linked respiration and decreased maximal and spare respiratory capacities. Basal ATP levels but not lactate or LDH activity were increased in samples from proliferative-derived compared to differentiated-derived HepaRG. Further extracellular acidification rate (ECAR) experiments revealed parameters associated with glycolysis and oxidative phosphorylation. Under basal conditions, cells derived from both cultures had similar ECARs; however, under stressed conditions, proliferative-derived HepaRG had increases in ECAR capacity and apparent glycolytic reserve. The biguanide metformin has been reported to protect differentiated HepaRG against acetaminophen (APAP)-induced cell injury, as well as offer protection against bioenergetic deficiencies; therefore, we studied the outcome of exposure to these drugs in both culture conditions. Proliferative- and differentiated-derived cells were found to have distinct mitochondrial bioenergetic alterations when exposed to the hepatotoxic drug APAP. Metformin offered protection against loss of APAP-induced cellular viability and prevented APAP-induced decreases in bioenergetics in differentiated- but not proliferative-derived HepaRG. Distinguishingly, treatment with metformin alone reduced ATP-linked respiration, maximal respiratory capacity, and basal respiration in proliferative-derived HepaRG. Our results support that HepaRG represents an appropriate model to study drug-induced bioenergetic dysfunction.
HepaRG 是人肝癌衍生的增殖细胞系,可分化为肝细胞样和胆管细胞样细胞。分化的 HepaRG 培养物保持关键的肝功能,包括药物转运体和外源性化合物代谢酶。为了深入了解增殖和分化的 HepaRG 代谢,我们分析了各种生物能量参数,并研究了细胞培养物中三磷酸腺苷 (ATP)、乳酸和乳酸脱氢酶 (LDH) 活性的水平。与分化衍生的 HepaRG 相比,增殖培养物的细胞基础和与 ATP 相关的呼吸增加,而最大和备用呼吸能力降低。与分化衍生的 HepaRG 相比,增殖衍生的 HepaRG 中基础 ATP 水平升高,但乳酸或 LDH 活性没有升高。进一步的细胞外酸化率 (ECAR) 实验揭示了与糖酵解和氧化磷酸化相关的参数。在基础条件下,两种培养物来源的细胞具有相似的 ECAR;然而,在应激条件下,增殖衍生的 HepaRG 的 ECAR 能力和表观糖酵解储备增加。二甲双胍已被报道可保护分化的 HepaRG 免受对乙酰氨基酚 (APAP) 诱导的细胞损伤,并可提供对生物能量缺陷的保护;因此,我们在两种培养条件下研究了暴露于这些药物的结果。当暴露于肝毒性药物 APAP 时,增殖和分化衍生的细胞被发现具有明显的线粒体生物能量改变。二甲双胍可防止 APAP 诱导的细胞活力丧失,并防止分化衍生的 HepaRG 中的生物能量降低,但不能防止增殖衍生的 HepaRG 中的生物能量降低。值得注意的是,单独用二甲双胍处理可降低增殖衍生 HepaRG 中的 ATP 相关呼吸、最大呼吸能力和基础呼吸。我们的结果支持 HepaRG 是研究药物诱导的生物能量功能障碍的合适模型。